Home / Health Conditions / Parkinson’s Disease
Parkinson’s Disease
A progressive condition in which brain cells that make dopamine are lost, causing tremor, stiffness, slowness and many non-movement symptoms. There is no cure yet, but medicines, exercise, therapy and sometimes surgery can ease symptoms — and stopping Parkinson’s medicine suddenly, choking, or a fall with injury needs urgent care.
Call 911 if someone with Parkinson’s is choking, can’t breathe, or suddenly can’t swallow. Food stuck in the throat can block the airway, and a brain without oxygen for more than four minutes can be damaged (MedlinePlus (opens in a new tab)). Coughing or choking with meals, a wet, gurgly voice after eating or repeated chest infections need prompt medical advice (NHS (opens in a new tab)).
Never stop levodopa or other Parkinson’s medicines suddenly, and don’t skip doses. FDA labels warn that abruptly cutting or stopping them can trigger a rare, life-threatening illness resembling neuroleptic malignant syndrome: fever, marked muscle rigidity, confusion and a racing heart (FDA label, Sinemet (opens in a new tab)). Stopping amantadine suddenly has caused a “parkinsonian crisis,” a sudden marked decline (FDA label, amantadine (opens in a new tab)). Fever with new stiffness and confusion after missed or stopped medicine is a reason to call 911.
Get emergency care after a fall with a head injury or suspected broken bone, or if you can’t get up. Most people with Parkinson’s fall at least once (Cochrane review, 2022 (opens in a new tab)).
Call the prescriber promptly about new hallucinations, delusions or confusion. Parkinson’s medicines can cause them, and they may respond to a dose change — made only by the prescriber (FDA label, Sinemet (opens in a new tab)). Call 911 if the person is in danger.
Some common medicines make Parkinson’s worse. The metoclopramide (reflux and stomach-emptying medicine) label says to avoid it in Parkinson’s (FDA label, metoclopramide (opens in a new tab)), and haloperidol’s label lists Parkinson’s as a contraindication (FDA label, haloperidol (opens in a new tab)). Tell every emergency room, hospital and pharmacist you have Parkinson’s (see Medicines that can make Parkinson’s worse below).
If you have thoughts of suicide, call or text 988 (24/7) (988 Lifeline (opens in a new tab)). Levodopa labels ask that people be watched for depression with suicidal thoughts (FDA label, Sinemet (opens in a new tab)).
What is Parkinson’s disease?
Parkinson’s disease (PD) is a movement disorder that happens when nerve cells in the brain don’t make enough of the chemical dopamine (MedlinePlus (opens in a new tab)). The loss is in a part of the brain called the substantia nigra (NHS (opens in a new tab)). It is the most common form of parkinsonism, the group of conditions with Parkinson-like slowness, stiffness and tremor (JAMA review, 2020 (opens in a new tab)). Symptoms begin gradually, often on one side of the body, and later reach both sides (MedlinePlus (opens in a new tab)). There is no cure, and no disease-modifying medicines are available yet (JAMA review, 2020 (opens in a new tab)). It varies a lot: one review describes a mild, slowly progressing form in about half of people (49–53%) and a faster, more severe form in 9–16% (JAMA review, 2020 (opens in a new tab)).
Who gets it, and why?
Symptoms usually begin around age 60 but can start earlier, and it is more common in men (MedlinePlus (opens in a new tab)). More than 6 million people worldwide have it (JAMA review, 2020 (opens in a new tab)). Most experts think a combination of genetic and environmental factors is responsible (NHS (opens in a new tab)). About 15% of people have a family history, and changes in genes such as LRRK2, SNCA, PINK1 and PRKN can cause familial cases; most cases appear with no family history (MedlinePlus Genetics (opens in a new tab)).
Early signs and symptoms
The order and severity differ for each person, and few people have all of them (NHS (opens in a new tab)).
Movement (motor) symptoms
- Tremor — usually starting in a hand or arm, more likely when the limb is resting.
- Slowness (bradykinesia) — everyday tasks get harder and walking may become a shuffle with very small steps.
- Stiffness (rigidity) — muscle tension that makes movement and facial expressions difficult and can cause painful cramps (dystonia) (NHS (opens in a new tab)); see our Dystonia guide.
- Poor balance, which can lead to falls (NHS (opens in a new tab)).
Non-movement (non-motor) symptoms
These can be as troubling as the movement symptoms: loss of smell (sometimes years before other symptoms), nerve pain, bladder problems, constipation, dizziness or fainting on standing, swallowing trouble, drooling, poor sleep, depression, anxiety, memory and planning problems and, in some people, dementia with hallucinations (NHS (opens in a new tab)). Acting out dreams (REM sleep behavior disorder), loss of smell and constipation can come before the movement symptoms (JAMA review, 2020 (opens in a new tab)). Constipation was linked to a higher chance of later developing Parkinson’s in a 2023 analysis (meta-analysis, PubMed (opens in a new tab)), but constipation is very common and by itself rarely means Parkinson’s. See our Bowel Problems, Bladder Problems and Nerve Damage guides.
How it’s diagnosed
There is no specific test. Doctors use your medical history and a neurological exam (MedlinePlus (opens in a new tab)); early on, even a doctor may not be sure (NHS (opens in a new tab)). If Parkinson’s is suspected, you will usually be referred to a neurologist or geriatrician (NHS (opens in a new tab)).
- DaTscan is a nuclear-medicine brain scan (SPECT) of dopamine transporters. Its FDA label calls it an adjunct to other evaluations in adults with suspected parkinsonian syndromes or dementia with Lewy bodies, and notes it was not designed to tell Parkinson’s from multiple system atrophy or progressive supranuclear palsy (FDA label, DaTscan (opens in a new tab)). It can improve accuracy when it is uncertain whether parkinsonism is present (JAMA review, 2020 (opens in a new tab)).
- Accuracy. In a 2002 study, a specialist service’s clinical diagnosis of Parkinson’s was confirmed in 72 of 73 cases (study, PubMed (opens in a new tab)). In a 2025 study of 1,626 people diagnosed by neurologists, about 13% of diagnoses were later revised, mostly within two years (study, PubMed (opens in a new tab)). If your picture changes, it is reasonable to ask for a second look.
- Medicine-caused parkinsonism. Metoclopramide can cause Parkinson-like symptoms that generally fade 2 to 3 months after stopping (FDA label, metoclopramide (opens in a new tab)). Give your doctor a full medicine list.
Outlook
Parkinson’s progresses over many years. The NHS says many people respond well to treatment and have only mild to moderate disability, while a minority become more severely disabled. It doesn’t directly cause death, but can make people more vulnerable to serious infections, and most people now have a normal or near-normal life expectancy (NHS (opens in a new tab)). That is a UK summary; ask your neurologist about your own outlook.
Side by side
Six approaches compared
For every condition we look at the same six approaches: what each involves, what it typically costs, and what a patient can realistically expect.
| Approach | What it involves | Estimated cost | What to expect |
|---|---|---|---|
| Conventional medicine (AMA) | Care from a neurologist, ideally one who focuses on movement disorders: levodopa (with carbidopa) and other medicine classes — dopamine agonists, MAO-B inhibitors, COMT inhibitors, amantadine and anticholinergics — plus physical, occupational and speech therapy, and for selected people deep brain stimulation, focused ultrasound or pump-delivered medicine. | Medicare Part B covers medically necessary outpatient physical, occupational and speech-language therapy (20% after the deductible). Self-pay therapy, medicines, specialist visits, scans and surgery: cost estimate being researched. | No cure, but medicines can sometimes help symptoms dramatically, especially early. Over the years, doses wear off sooner and involuntary movements (dyskinesias) can appear, and medicines can cause sleepiness, hallucinations or compulsive behaviors. Surgery helps selected people but has real risks. |
| Chiropractic | No chiropractic treatment has been shown to treat Parkinson’s disease. At most, gentle soft-tissue work or posture advice from a practitioner who understands Parkinson’s and works with your neurologist. | About $90–$200 for a first appointment and $55–$100 for a self-pay follow-up visit. | We found only case reports and a tiny pilot study that measured brain-wave recordings, not symptoms. Neck manipulation has been linked to rare artery tears and stroke. Avoid high-velocity neck manipulation. |
| Acupuncture | Fine needles, usually added to regular medical care, tried for movement symptoms, constipation, sleep and mood. | About $125–$230 for a first visit and $90–$185 for follow-ups; community clinics about $50–$90. | Several small reviews report benefits, but the studies differ a great deal in design and quality, so the evidence is promising but not firm. It is a comfort-focused add-on, not a treatment for the disease itself. |
| Herbal medicine | No herb or supplement has been shown to slow or treat Parkinson’s. Mucuna pruriens contains levodopa, so it acts as a real dopamine medicine; coenzyme Q10 and vitamin E did not help in large trials. | Cost estimate being researched. | Supplements can interfere with Parkinson’s medicines — iron multivitamins can lower levodopa absorption and St. John’s wort can interact unpredictably. Tell your neurologist and pharmacist about everything you take. |
| Massage therapy | Therapeutic massage to ease muscle tension, pain and stress. | One national chain: about $125–$160 for a 60-minute massage for non-members, or a $70–$90 monthly membership. | Small studies suggest it may help relaxation, sleep, mood and some movement scores, though the research is limited. It does not treat the disease itself. Risk of harm appears low; avoid very deep, vigorous work. |
| MBHA Wellness Coach | Building routines around your care team’s plan: on-time medicine habits, a regular exercise program, a symptom diary, sleep and stress habits, constipation and fall-proofing routines, mood support and planning ahead. | MBHA coaching cost estimate being researched. | Supports — but doesn’t replace — medical care. Exercise is one of the best-supported things people with Parkinson’s can do, and steady medicine timing and fall-proofing matter day to day. |
Approach 1 of 6
Conventional medicine (AMA)
There is no cure, but treatment can relieve symptoms and maintain quality of life: supportive therapies, medicine and, for some, surgery (NHS (opens in a new tab)). You may not need medicine while symptoms are mild, but regular specialist visits let your condition be monitored (NHS (opens in a new tab)). We don’t list doses — only your prescriber sets or changes them. The safety points below come from FDA drug labels on DailyMed.
1. Levodopa with carbidopa
Most people eventually need levodopa, which the brain turns into dopamine (NHS (opens in a new tab)). Carbidopa keeps levodopa from breaking down outside the brain, so much lower levodopa doses can be used and nausea is reduced (FDA label, Sinemet (opens in a new tab)). At first it can cause a dramatic improvement, but over the years the effect lasts less long, and long-term use is linked to jerky involuntary movements (dyskinesias) and “on-off” swings (NHS (opens in a new tab)).
- Timing and food: take it at regular intervals on your doctor’s schedule. A high-protein meal may delay absorption, and iron salts — including multivitamins with iron — can reduce how much levodopa the body uses (FDA label, Sinemet (opens in a new tab)).
- Sudden sleep: people have fallen asleep suddenly, without warning, during daily activities including driving, and road accidents have been reported (FDA label, Sinemet (opens in a new tab)).
- Impulse-control problems: intense urges to gamble, spend, eat or have sex. People may not see it as abnormal; family often notice first. In some cases it stopped when the dose was lowered (FDA label, Sinemet (opens in a new tab)).
- Also on the label: hallucinations; and a 2- to 6-fold higher melanoma risk in people with Parkinson’s (unclear whether from the disease or treatment), so regular skin checks are advised (FDA label, Sinemet (opens in a new tab)).
2. Dopamine agonists
Pramipexole, ropinirole and the rotigotine patch substitute for dopamine, with a milder effect than levodopa (NHS (opens in a new tab)). Their labels list sudden sleep onset without warning (the NHS says people are usually advised not to drive while the dose is raised), impulse-control disorders, hallucinations and low blood pressure on standing (FDA label, pramipexole (opens in a new tab), FDA label, ropinirole (opens in a new tab), NHS (opens in a new tab)). Hallucinations were reported in 16.5% of people with advanced disease taking pramipexole versus 3.8% on placebo, and the risk rises with age (FDA label, pramipexole (opens in a new tab)). The ropinirole label recommends tapering to avoid the fever-and-rigidity illness above, and notes withdrawal symptoms (insomnia, apathy, anxiety, depression, pain) after stopping dopamine agonists (FDA label, ropinirole (opens in a new tab)).
3. MAO-B inhibitors
Selegiline and rasagiline block an enzyme that breaks down dopamine. Their effects are small compared with levodopa, but they can be used early or alongside it (NHS (opens in a new tab)). In a 1993 trial of 800 people, selegiline (then called deprenyl) delayed the need for levodopa by about nine months (DATATOP trial, PubMed (opens in a new tab)). Rasagiline’s label warns against combining it with meperidine, tramadol, methadone, other MAO inhibitors and many antidepressants (serotonin syndrome), and notes it can raise blood pressure (FDA label, Azilect (opens in a new tab)). The Zelapar label describes selegiline as an add-on for people whose levodopa response has worsened (FDA label, Zelapar (opens in a new tab)).
4. COMT inhibitors
Entacapone, opicapone and tolcapone keep levodopa from being broken down and are add-ons for “wearing-off” in later stages (NHS (opens in a new tab), FDA label, entacapone (opens in a new tab), FDA label, Ongentys (opens in a new tab)). Entacapone caused diarrhea in 10% of people versus 4% on placebo, which can signal drug-induced colitis (FDA label, entacapone (opens in a new tab)). Tolcapone has a boxed warning for potentially fatal liver failure, so it is generally reserved for people who can’t use other add-ons (FDA label, Tasmar (opens in a new tab)).
5. Amantadine
Amantadine is less effective than levodopa (FDA label, amantadine (opens in a new tab)); an extended-release form is approved for dyskinesia in people on levodopa (FDA label, Gocovri (opens in a new tab)). Side effects include hallucinations, confusion, dry mouth, constipation and low blood pressure on standing; it shouldn’t be stopped suddenly (FDA label, amantadine (opens in a new tab)).
6. Anticholinergics
Trihexyphenidyl is used with other medicines for Parkinson’s symptoms. People 65 and older should not usually take it because it is not as safe or effective as other options; dry mouth, constipation and confusion are common (MedlinePlus (opens in a new tab)). Benztropine’s label warns of confusion, occasional visual hallucinations, and reduced sweating that can lead to heat stroke (FDA label, benztropine (opens in a new tab)).
7. When pills aren’t enough
Apomorphine, injected under the skin, treats acute, intermittent “off” episodes in advanced disease; its label contraindicates ondansetron-type anti-nausea drugs because of profound low blood pressure and fainting (FDA label, Apokyn (opens in a new tab)). The NHS also describes continuous pump infusions, including a medicine pumped into the stomach through a tube, for severe fluctuations (NHS (opens in a new tab)).
8. Deep brain stimulation (DBS)
In DBS, electrodes in the brain send electrical pulses to the areas that control movement (MedlinePlus (opens in a new tab)), powered by a pacemaker-like device in the chest. It doesn’t cure Parkinson’s, and isn’t suitable for everyone (NHS (opens in a new tab)). In the PD SURG trial of 366 people, quality-of-life scores improved by 5.0 points with surgery plus medicine versus 0.3 with medicine alone at one year; 19% had serious surgery-related adverse events and one person died from the procedure (PD SURG trial, PubMed (opens in a new tab)). A 2024 review of seven trials rated the evidence very low certainty and found more serious adverse events, mainly brain bleeds, confusion after surgery and device problems (meta-analysis, PubMed (opens in a new tab)).
9. Focused ultrasound
Focused ultrasound uses imaging-guided sound waves to make a small lesion in a deep brain target on one side, without an incision. Sham-controlled trials found tremor improved 62% versus 22% in 27 people with tremor-dominant disease, with two cases of mild weakness (2017 trial, PubMed (opens in a new tab)); a motor-score gain in 40 people with one-sided symptoms, with speech disturbance in 15 (persisting in 3) and gait disturbance in 13 (persisting in 2) (2020 trial, PubMed (opens in a new tab)); and a response in 69% versus 32% of 94 people with dyskinesias or fluctuations, with slurred speech, gait, taste, vision and facial-weakness side effects. The authors called for longer, larger trials (2023 trial, PubMed (opens in a new tab)). Ask your neurologist whether you might be a candidate; the lesions are permanent.
10. Physical, occupational and speech therapy
Physiotherapists ease stiffness and improve walking, occupational therapists help with daily tasks and a safe home, and speech and language therapists teach speaking and swallowing exercises (NHS (opens in a new tab)). A Cochrane review of 39 trials (1,827 people) found physiotherapy improved walking speed, balance and clinician-rated disability in the short term, but not self-rated quality of life; most differences were small (Cochrane review, PubMed (opens in a new tab)). For swallowing, a 2026 Cochrane review found rehabilitation evidence very uncertain, so start with a swallowing evaluation by a speech-language pathologist (Cochrane review, PubMed (opens in a new tab)).
What it costs
- Therapy: Medicare Part B covers medically necessary outpatient physical therapy with no limit, and you pay 20% after the deductible (Medicare.gov (opens in a new tab)); occupational therapy and speech-language pathology are covered the same way (Medicare.gov (opens in a new tab), Medicare.gov (opens in a new tab)). Self-pay therapy cost: cost estimate being researched.
- Medicines, neurologist visits, DaTscan, DBS and focused ultrasound: cost estimate being researched.
How well it works — what to expect
Medicines sometimes help symptoms dramatically, and surgery can help severe cases (MedlinePlus (opens in a new tab)), but nothing cures Parkinson’s, and the plan is revisited as needs change.
Approach 2 of 6
Chiropractic
Chiropractic is a licensed health profession whose treatment usually involves hands-on therapy, often spinal manipulation. We found no good evidence that chiropractic care treats Parkinson’s disease. What exists is thin: a case report of one woman who felt better after 9 months of chiropractic rehabilitation, with no comparison (case report, PubMed (opens in a new tab)), and a 2024 crossover pilot of 14 people with Parkinson’s that tracked brain-wave recordings after one adjustment, not symptoms, whose authors urged caution (pilot trial, PubMed (opens in a new tab)).
Avoid high-velocity neck manipulation. Neck manipulation has been linked to small tears in neck arteries that are rare but can lead to a stroke (NCCIH (opens in a new tab)). Because balance problems and falls are common in Parkinson’s, MBHA suggests keeping any care gentle (soft-tissue work, stretching, posture advice), telling the practitioner about your condition and medicines, and not letting it replace your neurologist’s plan or exercise.
What it costs
About $90–$200 for a first appointment and $55–$100 for a self-pay follow-up visit (The Pricer (opens in a new tab)).
Approach 3 of 6
Acupuncture
Acupuncture is promising but not proven for Parkinson’s. The reviews below are mostly of small trials that added acupuncture to usual medicine:
- General symptoms: a 2022 review of 17 trials found positive effects, but the authors noted great discrepancies in study design that make comparison difficult (systematic review, PubMed (opens in a new tab)).
- Constipation: 11 trials (960 people) suggested more spontaneous bowel movements and better quality of life (meta-analysis, PubMed (opens in a new tab)).
- Sleep: 11 studies (800 people) reported better insomnia scores, with limitations noted (meta-analysis, PubMed (opens in a new tab)).
- Anxiety and depression: 26 trials (2,153 people); acupuncture plus Western medicine looked better than other treatments, but the authors said literature quality limits the conclusion (network meta-analysis, PubMed (opens in a new tab)).
There is an encouraging signal, but not enough high-quality evidence to say it treats the disease. If you try it, use it for comfort alongside your neurologist’s care.
Safety
Relatively few complications are reported, but nonsterile needles or improper delivery can cause infections, punctured organs and nervous-system injury (NCCIH (opens in a new tab)). Choose a licensed acupuncturist, and get up slowly after sessions if you get dizzy on standing.
What it costs
About $125–$230 for a first private visit and $90–$185 for follow-ups; community clinics about $50–$90 (The Pricer (opens in a new tab)).
Approach 4 of 6
Herbal medicine
No herb or supplement has been proven to treat or slow Parkinson’s. The NHS says there is no clinical evidence that complementary treatments control the symptoms, that some can be harmful, and that they should not replace prescribed medicines (NHS (opens in a new tab)).
Mucuna pruriens
This tropical legume naturally contains levodopa, so it is a real dopamine drug (review, PubMed (opens in a new tab)). A small 2026 open-label trial in sub-Saharan Africa (32 untreated people, where levodopa is hard to get) found similar outcomes to standard levodopa-carbidopa over 12 months, with more side effects on mucuna (56% versus 37.5%, not statistically significant) (randomized trial, PubMed (opens in a new tab)). Specialists caution that overuse and self-treatment have been linked to dyskinesia, compulsive medicine use and psychiatric problems, and badly prepared seeds to toxicity, and advise limiting use to trials or neurologist-led plans until long-term safety is clearer (review, PubMed (opens in a new tab), expert recommendations, PubMed (opens in a new tab)). Levodopa labels also say not to add other levodopa preparations without asking your doctor (FDA label, Sinemet (opens in a new tab)).
Antioxidants
- Coenzyme Q10: a phase III trial of 600 people with early disease was stopped for futility; it was safe but showed no clinical benefit (randomized trial, PubMed (opens in a new tab)).
- Vitamin E: in the 800-person DATATOP trial it did not slow progression (DATATOP trial, PubMed (opens in a new tab)).
Interactions with your medicines
- Iron in multivitamins can reduce levodopa absorption, and a high-protein diet can delay it (FDA label, Sinemet (opens in a new tab)).
- Vitamin B6: on its own it can reverse levodopa’s effect, but carbidopa blocks this, so carbidopa-levodopa can be given with B6 supplements. Treatment may also lower B6 levels, with rare seizures reported, so ask about B6 testing (FDA label, Sinemet (opens in a new tab)).
- St. John’s wort can interact unpredictably with some Parkinson’s medicines (NHS (opens in a new tab)) and dangerously with many others (NCCIH (opens in a new tab)).
Talk to your neurologist and pharmacist before taking any supplement or herb. We don’t list doses here.
Approach 5 of 6
Massage therapy
Massage doesn’t treat the cause of Parkinson’s, but it may ease tension, pain and stress, and some research hints at movement benefits.
- 2022 meta-analysis: eight small studies (363 people) found therapeutic massage improved motor scores more than controls, but not daily living activities (meta-analysis, PubMed (opens in a new tab)).
- 2020 review: 12 studies suggested better relaxation, sleep, pain, anxiety and quality of life with several styles; one technique combined with acupuncture was linked to worse motor scores. The authors noted methodological concerns (systematic review, PubMed (opens in a new tab)).
The evidence is encouraging for comfort and well-being but too limited to call massage a treatment for the disease.
Safety
The risk of harm appears low, but rare serious problems (a blood clot, nerve injury, bone fracture) have been reported, some after vigorous deep-tissue massage or in people at higher risk of injury, such as older adults (NCCIH (opens in a new tab)). MBHA suggests a therapist who knows you have Parkinson’s, moderate pressure, and getting up slowly from the table.
What it costs
At one national chain, a 60-minute massage costs about $125–$160 for non-members at the locations The Pricer checked, and memberships run about $70–$90 a month for one session (The Pricer (opens in a new tab)). Tips are extra.
Approach 6 of 6
MBHA Wellness Coach
An MBHA Wellness Coach can help you build habits around your care team’s plan — always alongside medical care, never instead of it. Coaching doesn’t diagnose, adjust medicines or treat the disease.
Medicine routines
Levodopa is meant to be taken at regular intervals (FDA label, Sinemet (opens in a new tab)), and timing slips easily: in a study of unplanned hospital stays, 51.7% of doses were given more than 30 minutes late (hospital study, PubMed (opens in a new tab)). A coach can help you set reminders, carry a current medicine list, and prepare a one-page sheet with your dose times for hospital visits.
Symptom diary
The levodopa label notes that “wearing-off” can happen at the end of a dose interval and should be reported if it causes problems (FDA label, Sinemet (opens in a new tab)). A diary of your best and worst times, meals, sleepiness, dizziness and mood gives your neurologist what they need.
Exercise, food, sleep and mood
Regular exercise relieves stiffness, improves mood and eases stress; the NHS suggests vigorous activity if symptoms are mild and gentler walking, stretching and strengthening if they are advancing (NHS (opens in a new tab)). A coach can help you pick an activity (see the exercise section below) and keep to it. The NHS suggests more fiber and fluids for constipation, and bedtime-routine changes for insomnia (NHS (opens in a new tab)). For low mood, see our Anxiety and Depression guides; support groups help many people (NHS (opens in a new tab)). If you have thoughts of suicide, call or text 988 (988 Lifeline (opens in a new tab)).
Care partners
Partners and carers often feel anxious or frustrated too; being open about how you feel and what would help can ease the strain (NHS (opens in a new tab)). MBHA coaching cost estimate being researched.
Another approach
Medicines that can make Parkinson’s worse
Not every medicine is safe in Parkinson’s. These examples come from FDA labels and are not a complete list: check with your neurologist or pharmacist before any new prescription, over-the-counter product or hospital medicine. See also our Medication Safety guide.
- Metoclopramide: the label says to avoid it in Parkinson’s because of possible worsening, and it carries a boxed warning for tardive dyskinesia, a potentially irreversible movement disorder (FDA label, metoclopramide (opens in a new tab)).
- Antipsychotics: haloperidol is contraindicated in Parkinson’s (FDA label, haloperidol (opens in a new tab)), and the levodopa label says some psychosis medicines may worsen symptoms and reduce levodopa’s effect (FDA label, Sinemet (opens in a new tab)). Pimavanserin is labeled for hallucinations and delusions of Parkinson’s psychosis; antipsychotics carry a boxed warning of higher death risk in older adults with dementia-related psychosis (FDA label, Nuplazid (opens in a new tab)). Never change one on your own.
- Other combinations: nonselective MAO inhibitors are contraindicated with levodopa (FDA label, Sinemet (opens in a new tab)); rasagiline can cause serotonin syndrome with meperidine, tramadol or methadone (FDA label, Azilect (opens in a new tab)); and apomorphine is contraindicated with ondansetron-type drugs (FDA label, Apokyn (opens in a new tab)).
In hospital, ask that your medicines be given on your schedule. A study of unplanned admissions found errors in the timing of time-critical Parkinson’s medicines at admission in about a third of cases (hospital study, PubMed (opens in a new tab)).
Another approach
Exercise, tai chi, dance, boxing and speech therapy
Exercise is one of the best-supported things people with Parkinson’s can do. A Cochrane analysis of 154 trials (7,837 people) found benefits for most exercise types versus no exercise. Dance and gait, balance and functional training probably have a moderate benefit on motor signs, aquatic training probably a large benefit on quality of life, and there was little evidence that one type beats the others. Falls and pain were the most commonly reported problems (Cochrane review, 2024 (opens in a new tab)). Pick something you’ll keep doing, ideally in a program built for Parkinson’s.
- Tai chi: in a trial of 195 people, tai chi twice a week for 24 weeks improved balance control more than resistance training or stretching and cut falls compared with stretching, with no serious adverse events (New England Journal of Medicine trial, PubMed (opens in a new tab)). NCCIH says it may help balance and prevent falls in Parkinson’s, with low certainty (NCCIH (opens in a new tab)).
- Dance ranked among the best options for motor signs in the Cochrane analysis (Cochrane review, 2024 (opens in a new tab)).
- Boxing-style training: a 2019 review found only two small studies (37 people) and called the evidence limited (review, PubMed (opens in a new tab)); a 2024 meta-analysis of 13 studies found no significant pooled effect on mobility, balance or motor symptoms (meta-analysis, PubMed (opens in a new tab)). It can still be a fun, social option; choose a non-contact class with trained instructors.
- LSVT BIG and LOUD: LSVT BIG (16 sessions of large movements) beat general exercise on a motor score in three small trials of 84 people with mild disease (meta-analysis, PubMed (opens in a new tab)), though the Cochrane analysis rated its effect very uncertain. LSVT LOUD speech therapy raised vocal loudness across 10 trials (meta-analysis, PubMed (opens in a new tab)); an older Cochrane review of speech therapy found loudness gains but called the evidence insufficient because studies were small (Cochrane review, PubMed (opens in a new tab)).
Another approach
Preventing falls and dizziness on standing
A Cochrane review of 32 trials (3,370 people) found that exercise probably reduces the rate of falls in Parkinson’s by about 26%, and slightly reduces the number of people who fall; effects on fractures were uncertain (Cochrane review, 2022 (opens in a new tab)).
- Balance-challenging exercise: tai chi and gait and balance training (above).
- Dizziness on standing: a blood-pressure drop can cause dizziness, blurred vision or fainting (NHS (opens in a new tab)). Get up slowly, in stages (NHS (opens in a new tab)). Levodopa, dopamine agonists and blood-pressure medicines can add to it, so report new dizziness to your prescriber (FDA label, Sinemet (opens in a new tab), FDA label, ropinirole (opens in a new tab)).
- A safer home: an occupational therapist can help set your home up safely (NHS (opens in a new tab)).
For more on home safety and other causes of unsteadiness, see our Balance guide.
Another approach
Constipation, sleep, mood and swallowing
- Constipation: more fiber and fluids can help (NHS (opens in a new tab)), and anticholinergic medicines can cause it (MedlinePlus (opens in a new tab)). Tell your doctor if it is severe or new; see our Bowel Problems guide. (MBHA doesn’t yet have a separate constipation guide.)
- Sleep: insomnia and daytime sleepiness are common (NHS (opens in a new tab)), as is acting out dreams (JAMA review, 2020 (opens in a new tab)). A bedtime routine can help (NHS (opens in a new tab)). Report any sudden sleep episodes to your prescriber right away.
- Depression and anxiety: in a trial of 72 people, 10 sessions of telephone-based cognitive behavioral therapy reduced depression more than usual care, with gains lasting 6 months (randomized trial, PubMed (opens in a new tab)). A 2025 meta-analysis of 11 trials (713 people) found newer antidepressants improved depressive symptoms and anxiety (meta-analysis, PubMed (opens in a new tab)); rasagiline and antidepressants can interact, so coordinate them. See our Depression and Anxiety guides; call or text 988 in a crisis.
- Swallowing and drooling: a speech and language therapist can teach swallowing exercises; softened foods or, in severe cases, a feeding tube may be needed (NHS (opens in a new tab)).
Another approach
Driving and working
A review found driving is impaired in people with Parkinson’s compared with healthy drivers (evidence review, PubMed (opens in a new tab)). A 2024 review of 15 guidelines found a driving evaluation should include movement, thinking, vision and sleep assessment and a medication review, and that most allowed conditional licenses (guideline review, PubMed (opens in a new tab)).
- Anyone who has had sudden sleep episodes or significant sleepiness on levodopa should not drive (FDA label, Sinemet (opens in a new tab)).
- Ask your neurologist when to be assessed. Rules differ by place; in the UK, people must tell the driving agency and their insurer but needn’t necessarily stop (NHS (opens in a new tab)). Check your own state’s rules.
- A diagnosis doesn’t mean you must stop working; many people keep working for years (NHS (opens in a new tab)).
Another approach
Advanced Parkinson’s and planning ahead
Over time, medicines may stop controlling symptoms consistently. The NHS calls this complex Parkinson’s; it can still be helped by adjusting medicines under a specialist (NHS (opens in a new tab)), and pumps or DBS may be considered (JAMA review, 2020 (opens in a new tab)). Hallucinations and dementia can occur (NHS (opens in a new tab)).
Palliative care is for symptom relief and support at any stage, not only the end of life (NHS (opens in a new tab)). In a trial of 210 people with Parkinson’s and related disorders, outpatient palliative care improved quality of life at 6 months and, by 12 months, was linked to less severe symptoms, more completed advance directives and less caregiver anxiety (randomized trial, PubMed (opens in a new tab)). Consider writing down your wishes and talking with family early. Our ALS guide also covers advance care planning for another progressive nerve disease.
Member stories
Living with Parkinson’s Disease? Share your experience
Real experiences help others choose. Tell us what you tried — conventional medicine, chiropractic, acupuncture, herbs, massage or coaching — what it cost and what changed.
Sources
- MedlinePlus — Parkinson's disease (health topic) (opens in a new tab)
- MedlinePlus Genetics — Parkinson's disease (opens in a new tab)
- MedlinePlus — Trihexyphenidyl (drug information) (opens in a new tab)
- MedlinePlus — Choking (opens in a new tab)
- NHS — Parkinson's disease (opens in a new tab)
- NHS — Parkinson's disease: symptoms (opens in a new tab)
- NHS — Parkinson's disease: diagnosis (opens in a new tab)
- NHS — Parkinson's disease: treatment (opens in a new tab)
- NHS — Parkinson's disease: living with (opens in a new tab)
- NHS — Dysphagia (swallowing problems) (opens in a new tab)
- NHS — Low blood pressure (hypotension) (opens in a new tab)
- 988 Suicide and Crisis Lifeline (opens in a new tab)
- FDA label (DailyMed) — Sinemet (carbidopa and levodopa) tablets (opens in a new tab)
- FDA label (DailyMed) — Pramipexole tablets (opens in a new tab)
- FDA label (DailyMed) — Ropinirole tablets (opens in a new tab)
- FDA label (DailyMed) — Azilect (rasagiline) tablets (opens in a new tab)
- FDA label (DailyMed) — Zelapar (selegiline) orally disintegrating tablets (opens in a new tab)
- FDA label (DailyMed) — Entacapone tablets (opens in a new tab)
- FDA label (DailyMed) — Ongentys (opicapone) capsules (opens in a new tab)
- FDA label (DailyMed) — Tasmar (tolcapone) tablets (opens in a new tab)
- FDA label (DailyMed) — Amantadine (opens in a new tab)
- FDA label (DailyMed) — Gocovri (amantadine) extended-release capsules (opens in a new tab)
- FDA label (DailyMed) — Benztropine mesylate tablets (opens in a new tab)
- FDA label (DailyMed) — Apokyn (apomorphine) injection (opens in a new tab)
- FDA label (DailyMed) — Nuplazid (pimavanserin) (opens in a new tab)
- FDA label (DailyMed) — Metoclopramide tablets (opens in a new tab)
- FDA label (DailyMed) — Haloperidol tablets (opens in a new tab)
- FDA label (DailyMed) — DaTscan (ioflupane I-123) injection (opens in a new tab)
- NCCIH — Tai chi: what you need to know (opens in a new tab)
- NCCIH — Acupuncture: effectiveness and safety (opens in a new tab)
- NCCIH — Massage therapy: what you need to know (opens in a new tab)
- NCCIH — Spinal manipulation: what you need to know (opens in a new tab)
- NCCIH — St. John's wort (opens in a new tab)
- Medicare.gov — Physical therapy services (opens in a new tab)
- Medicare.gov — Occupational therapy services (opens in a new tab)
- Medicare.gov — Speech-language pathology services (opens in a new tab)
- The Pricer — Chiropractor and chiropractic treatment cost (opens in a new tab)
- The Pricer — Acupuncture cost (opens in a new tab)
- The Pricer — Massage Envy cost (opens in a new tab)
- Diagnosis and treatment of Parkinson disease: a review, JAMA, 2020 (PubMed abstract) (opens in a new tab)
- The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service, Brain, 2002 (PubMed abstract) (opens in a new tab)
- Stability and accuracy of a diagnosis of Parkinson disease over 10 years, Neurology, 2025 (PubMed abstract) (opens in a new tab)
- Constipation in Parkinson's disease: a systematic review and meta-analysis, European Neurology, 2023 (PubMed abstract) (opens in a new tab)
- Parkinson Study Group — Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease (DATATOP), New England Journal of Medicine, 1993 (PubMed abstract) (opens in a new tab)
- Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial), Lancet Neurology, 2010 (PubMed abstract) (opens in a new tab)
- Deep brain stimulation for Parkinson's disease: systematic review with meta-analysis and trial sequential analysis, BMJ Medicine, 2024 (PubMed abstract) (opens in a new tab)
- Safety and efficacy of focused ultrasound thalamotomy for medication-refractory, tremor-dominant Parkinson disease: a randomized clinical trial, JAMA Neurology, 2017 (PubMed abstract) (opens in a new tab)
- Randomized trial of focused ultrasound subthalamotomy for Parkinson's disease, New England Journal of Medicine, 2020 (PubMed abstract) (opens in a new tab)
- Trial of globus pallidus focused ultrasound ablation in Parkinson's disease, New England Journal of Medicine, 2023 (PubMed abstract) (opens in a new tab)
- Physiotherapy versus placebo or no intervention in Parkinson's disease, Cochrane Database of Systematic Reviews, 2013 (PubMed abstract) (opens in a new tab)
- Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease, Cochrane Database of Systematic Reviews, 2012 (PubMed abstract) (opens in a new tab)
- Rehabilitation interventions for oropharyngeal dysphagia in people with Parkinson's disease, Cochrane Database of Systematic Reviews, 2026 (PubMed abstract) (opens in a new tab)
- Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis, Cochrane Database of Systematic Reviews, 2024 (PubMed abstract) (opens in a new tab)
- Interventions for preventing falls in Parkinson's disease, Cochrane Database of Systematic Reviews, 2022 (PubMed abstract) (opens in a new tab)
- Lee Silverman Voice Treatment to improve speech in Parkinson's disease: a systematic review and meta-analysis, Parkinson's Disease, 2021 (PubMed abstract) (opens in a new tab)
- Lee Silverman Voice Treatment (LSVT)-BIG to improve motor function in people with Parkinson's disease: a systematic review and meta-analysis, Clinical Rehabilitation, 2018 (PubMed abstract) (opens in a new tab)
- Tai chi and postural stability in patients with Parkinson's disease, New England Journal of Medicine, 2012 (PubMed abstract) (opens in a new tab)
- Boxing for Parkinson's disease: has implementation accelerated beyond current evidence? Frontiers in Neurology, 2019 (PubMed abstract) (opens in a new tab)
- The efficacy of boxing training on patients with Parkinson's disease: systematic review and meta-analysis, Revista de Neurologia, 2024 (PubMed abstract) (opens in a new tab)
- Parkinson's disease medication prescribing and administration during unplanned hospital admissions, Movement Disorders Clinical Practice, 2022 (PubMed abstract) (opens in a new tab)
- Comparison of integrated outpatient palliative care with standard care in patients with Parkinson disease and related disorders: a randomized clinical trial, JAMA Neurology, 2020 (PubMed abstract) (opens in a new tab)
- Parkinson disease and driving: an evidence-based review, Neurology, 2012 (PubMed abstract) (opens in a new tab)
- Parkinson's disease and driving fitness: a systematic review of the existing guidelines, Movement Disorders Clinical Practice, 2024 (PubMed abstract) (opens in a new tab)
- Telephone-based cognitive behavioral therapy for depression in Parkinson disease: a randomized controlled trial, Neurology, 2020 (PubMed abstract) (opens in a new tab)
- Efficacy and safety of newer-generation antidepressant medications in Parkinson's disease with depression: a meta-analysis of randomized controlled trials, Journal of Psychiatric Research, 2025 (PubMed abstract) (opens in a new tab)
- Effectiveness of acupuncture in Parkinson's disease symptoms: a systematic review, Healthcare, 2022 (PubMed abstract) (opens in a new tab)
- Acupuncture for constipation in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials, Medicine, 2024 (PubMed abstract) (opens in a new tab)
- Acupuncture for the anxiety and depression in Parkinson disease: a systematic review and network meta-analysis, Medicine, 2025 (PubMed abstract) (opens in a new tab)
- The efficacy and safety of acupuncture for Parkinson's disease insomnia: a systematic review and meta-analysis, Frontiers in Neurology, 2025 (PubMed abstract) (opens in a new tab)
- Effectiveness of therapeutic massage for improving motor symptoms in Parkinson's disease: a systematic review and meta-analysis, Frontiers in Neurology, 2022 (PubMed abstract) (opens in a new tab)
- Massage therapy as a complementary treatment for Parkinson's disease: a systematic literature review, Complementary Therapies in Medicine, 2020 (PubMed abstract) (opens in a new tab)
- The effects of chiropractic spinal adjustment on EEG in adults with Alzheimer's and Parkinson's disease: a pilot randomised cross-over trial, Journal of Integrative Neuroscience, 2024 (PubMed abstract) (opens in a new tab)
- Chiropractic care of Parkinson's disease and deformity, Journal of Medicine and Life, 2022 (PubMed abstract) (opens in a new tab)
- Mucuna pruriens in untreated Parkinson's disease in sub-Saharan Africa: a 12-month, multicenter, randomized, controlled trial, Journal of Parkinson's Disease, 2026 (PubMed abstract) (opens in a new tab)
- Mucuna pruriens to treat Parkinson's disease in low-income countries: recommendations and practical guidelines, Parkinsonism and Related Disorders, 2024 (PubMed abstract) (opens in a new tab)
- “To bean or not to bean”: advice to people with Parkinson in my clinic about Mucuna pruriens, Journal of Parkinson's Disease, 2026 (PubMed abstract) (opens in a new tab)
- A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, JAMA Neurology, 2014 (PubMed abstract) (opens in a new tab)
This page is for education only and is not medical advice. Costs are typical U.S. ranges and estimates; yours will depend on your provider, location and insurance. Talk with your doctor before starting, stopping or combining any treatment. In an emergency, call 911. See our disclaimer.
Find the right practitioner
Search MBHA’s Health Directory for doctors, chiropractors, acupuncturists and massage therapists across the Monterey Bay.